G. Walmsley Graham - 01 Jun 2021 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Director
Signature
/s/ Jonathan Young, attorney-in-fact
Issuer symbol
AKRO
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
03 Jun 2021, 17:55:36 UTC
Next filing
10 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Award $0 +13,000 $0.000000 13,000 01 Jun 2021 Common Stock 13,000 $26.32 Direct F1
transaction AKRO Stock Option (Right to Buy) Gift $0 -13,000 -100% $0.000000* 0 01 Jun 2021 Common Stock 13,000 $26.32 Direct F1, F2
transaction AKRO Stock Option (Right to Buy) Gift $0 -23,832 -100% $0.000000* 0 01 Jun 2021 Common Stock 23,832 $19.97 Direct F3
transaction AKRO Stock Option (Right to Buy) Gift $0 -13,000 -100% $0.000000* 0 01 Jun 2021 Common Stock 13,000 $25.20 Direct F2, F5
holding AKRO Stock Option (Right to Buy) 13,000 01 Jun 2021 Common Stock 13,000 $26.32 See footnote F1, F2
holding AKRO Stock Option (Right to Buy) 23,832 01 Jun 2021 Common Stock 23,832 $19.97 See footnote F3, F4
holding AKRO Stock Option (Right to Buy) 13,000 01 Jun 2021 Common Stock 13,000 $25.20 See footnote F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full upon the earlier of (i) June 1, 2022 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.
F2 On June 1, 2021, the reporting person transferred 13,000 options to an entity of which the reporting person is the sole member.
F3 This option shall vest and become exercisable in 36 equal monthly installments, commencing on November 8, 2019.
F4 On June 1, 2021, the reporting person transferred 23,832 options to an entity of which the reporting person is the sole member.
F5 This option is fully vested.
F6 On June 1, 2021, the reporting person transferred 13,000 options to an entity of which the reporting person is the sole member.